Sunday November 22 2009 | Biotechnology feed | All feeds
|
|
Collateral Therapeutics Incorporated
Download detailed PDF Members: Collateral's initial non-surgical gene therapy products under investigation are designed to promote and enhance angiogenesis, a natural biological process which results in the growth of additional blood vessels, to increase levels of blood flow to oxygen-deprived tissues.
This page has been viewed 500 times since April 2007, the link to the organisation's website has been followed 99 times Search for more companies in San Diego Search for more companies in ca This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for Collateral Therapeutics Incorporated | ||||||||||||||||||||||||||||||||||||||
|